1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Lin, D.
Tsui, V.
Case, D.
Yuan, Y.C.
Chen, Y.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be Published
0353
HUMAN MRF-2 DOMAIN, NMR, 11 STRUCTURES
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
5
959
964
10.1038/2934
A Novel DNA-Binding Motif Shares Structural Homology to DNA Replication and Repair Nucleases and Polymerases
1998
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
11
459
460
10.1023/A:1008231900431
Resonance Assignments of the MRF-2 DNA-Binding Domain
1998
10.2210/pdb1ig6/pdb
pdb_00001ig6
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12652.646
MODULATOR RECOGNITION FACTOR 2
DNA-BINDING DOMAIN
1
man
polymer
MRF-2
no
no
RADEQAFLVALYKYMKERKTPIERIPYLGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRH
YERLILPYERFIKGEEDKPLPPIKPRK
RADEQAFLVALYKYMKERKTPIERIPYLGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRH
YERLILPYERFIKGEEDKPLPPIKPRK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
MRF-2
9606
Homo sapiens
469008
Escherichia coli BL21(DE3)
BL21 DE3
PLASMID
PQE30
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2001-04-25
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
2001-05-02
SPRSDE
1BMY is low quality structure of Human MRF-2 Domain
RCSB
Y
RCSB
2001-04-17
REL
REL
This structure was determined using the restraints derived from NMR experiments (NOE, dihedral angles, hydrogen bonds, residual dipolar coupling constants, etc.)
structures with acceptable covalent geometry,structures with the least restraint violations,structures with the lowest energy
100
11
3D_13C-separated_NOESY
3D_15N-separated_NOESY
3D HNHB
3D_15N_TOCSY-HSQC
3D HCCH-TOCSY
2D_PFG-SE-IPAP
100 mM Sodium Phosphate
6.00
ambient
298
K
The structures are based on a total of 2478 restraints, 2290 are NOE-derived distance constraints, 74 dihedral angle restraints, 42 distance restraints from hydrogen bonds, 35 residual dipolar coupling constants.
torsion angle dynamics
1
closest to the average
0.7 mM MRF-2 U-15N,13C, 100mM PHOSPHATE BUFFER NA, 0.02% NAN3, 5 mM DDT
90% H2O/10% D2O
0.7 mM MRF-2 U-15N,13C, 100mM PHOSPHATE BUFFER NA, 0.02% NAN3, 5 mM DDT
100% D2O
Biosym/MSI
processing
Felix
98.0
Peter Guntert, et al.
structure solution
DYANA
1.5
Kollman, Case, Merz, Cheatham, Simmerling, Pearlman
refinement
Amber
7.0
Varian Associates INC
collection
VNMR
6.1
500
Varian
UNITYPLUS
ARG
1
n
1
ARG
1
A
ALA
2
n
2
ALA
2
A
ASP
3
n
3
ASP
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
ALA
6
n
6
ALA
6
A
PHE
7
n
7
PHE
7
A
LEU
8
n
8
LEU
8
A
VAL
9
n
9
VAL
9
A
ALA
10
n
10
ALA
10
A
LEU
11
n
11
LEU
11
A
TYR
12
n
12
TYR
12
A
LYS
13
n
13
LYS
13
A
TYR
14
n
14
TYR
14
A
MET
15
n
15
MET
15
A
LYS
16
n
16
LYS
16
A
GLU
17
n
17
GLU
17
A
ARG
18
n
18
ARG
18
A
LYS
19
n
19
LYS
19
A
THR
20
n
20
THR
20
A
PRO
21
n
21
PRO
21
A
ILE
22
n
22
ILE
22
A
GLU
23
n
23
GLU
23
A
ARG
24
n
24
ARG
24
A
ILE
25
n
25
ILE
25
A
PRO
26
n
26
PRO
26
A
TYR
27
n
27
TYR
27
A
LEU
28
n
28
LEU
28
A
GLY
29
n
29
GLY
29
A
PHE
30
n
30
PHE
30
A
LYS
31
n
31
LYS
31
A
GLN
32
n
32
GLN
32
A
ILE
33
n
33
ILE
33
A
ASN
34
n
34
ASN
34
A
LEU
35
n
35
LEU
35
A
TRP
36
n
36
TRP
36
A
THR
37
n
37
THR
37
A
MET
38
n
38
MET
38
A
PHE
39
n
39
PHE
39
A
GLN
40
n
40
GLN
40
A
ALA
41
n
41
ALA
41
A
ALA
42
n
42
ALA
42
A
GLN
43
n
43
GLN
43
A
LYS
44
n
44
LYS
44
A
LEU
45
n
45
LEU
45
A
GLY
46
n
46
GLY
46
A
GLY
47
n
47
GLY
47
A
TYR
48
n
48
TYR
48
A
GLU
49
n
49
GLU
49
A
THR
50
n
50
THR
50
A
ILE
51
n
51
ILE
51
A
THR
52
n
52
THR
52
A
ALA
53
n
53
ALA
53
A
ARG
54
n
54
ARG
54
A
ARG
55
n
55
ARG
55
A
GLN
56
n
56
GLN
56
A
TRP
57
n
57
TRP
57
A
LYS
58
n
58
LYS
58
A
HIS
59
n
59
HIS
59
A
ILE
60
n
60
ILE
60
A
TYR
61
n
61
TYR
61
A
ASP
62
n
62
ASP
62
A
GLU
63
n
63
GLU
63
A
LEU
64
n
64
LEU
64
A
GLY
65
n
65
GLY
65
A
GLY
66
n
66
GLY
66
A
ASN
67
n
67
ASN
67
A
PRO
68
n
68
PRO
68
A
GLY
69
n
69
GLY
69
A
SER
70
n
70
SER
70
A
THR
71
n
71
THR
71
A
SER
72
n
72
SER
72
A
ALA
73
n
73
ALA
73
A
ALA
74
n
74
ALA
74
A
THR
75
n
75
THR
75
A
CYS
76
n
76
CYS
76
A
THR
77
n
77
THR
77
A
ARG
78
n
78
ARG
78
A
ARG
79
n
79
ARG
79
A
HIS
80
n
80
HIS
80
A
TYR
81
n
81
TYR
81
A
GLU
82
n
82
GLU
82
A
ARG
83
n
83
ARG
83
A
LEU
84
n
84
LEU
84
A
ILE
85
n
85
ILE
85
A
LEU
86
n
86
LEU
86
A
PRO
87
n
87
PRO
87
A
TYR
88
n
88
TYR
88
A
GLU
89
n
89
GLU
89
A
ARG
90
n
90
ARG
90
A
PHE
91
n
91
PHE
91
A
ILE
92
n
92
ILE
92
A
LYS
93
n
93
LYS
93
A
GLY
94
n
94
GLY
94
A
GLU
95
n
95
GLU
95
A
GLU
96
n
96
GLU
96
A
ASP
97
n
97
ASP
97
A
LYS
98
n
98
LYS
98
A
PRO
99
n
99
PRO
99
A
LEU
100
n
100
LEU
100
A
PRO
101
n
101
PRO
101
A
PRO
102
n
102
PRO
102
A
ILE
103
n
103
ILE
103
A
LYS
104
n
104
LYS
104
A
PRO
105
n
105
PRO
105
A
ARG
106
n
106
ARG
106
A
LYS
107
n
107
LYS
107
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
5
A
ARG
78
0.108
SIDE CHAIN
8
A
TYR
88
0.062
SIDE CHAIN
4
3.21
0.50
120.30
123.51
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
90
90
90
N
5
3.94
0.50
120.30
124.24
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
78
78
78
N
6
3.79
0.50
120.30
124.09
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
83
83
83
N
6
3.28
0.50
120.30
123.58
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
90
90
90
N
7
4.48
0.50
120.30
124.78
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
78
78
78
N
8
3.10
0.50
120.30
123.40
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
90
90
90
N
9
3.20
0.50
120.30
123.50
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
54
54
54
N
9
3.12
0.50
120.30
123.42
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
78
78
78
N
11
3.26
0.50
120.30
123.56
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
83
83
83
N
1
A
LEU
28
-64.35
-71.59
1
A
ASN
34
-141.29
51.97
1
A
SER
70
-141.87
48.23
1
A
ALA
74
64.87
-44.99
1
A
ILE
85
-158.01
-21.91
1
A
GLU
95
-142.03
22.86
1
A
GLU
96
-151.83
-46.40
2
A
ARG
18
-68.84
4.55
2
A
LYS
19
73.92
34.89
2
A
ILE
22
60.23
-34.23
2
A
LEU
28
-97.35
48.47
2
A
ILE
33
-63.69
99.30
2
A
SER
70
-78.15
24.33
2
A
ILE
85
-164.05
-21.78
2
A
LYS
93
-141.73
-15.02
2
A
GLU
96
34.17
82.62
2
A
LYS
98
-131.93
-39.07
2
A
ILE
103
45.12
29.42
3
A
PRO
21
-71.96
22.33
3
A
ILE
22
62.09
-20.11
3
A
ASN
34
-141.60
42.80
3
A
TYR
48
62.08
-45.82
3
A
ILE
85
-150.77
-24.13
3
A
GLU
96
31.42
48.43
3
A
ASP
97
-74.56
30.21
3
A
ILE
103
36.97
38.11
3
A
LYS
104
-155.52
63.33
4
A
ARG
18
-103.37
-77.42
4
A
LYS
19
176.06
15.44
4
A
PRO
26
-75.98
-168.86
4
A
LEU
28
-81.88
36.51
4
A
PHE
30
-143.42
-2.88
4
A
GLN
32
-78.33
37.87
4
A
ILE
33
53.44
71.12
4
A
ASN
34
-69.80
64.47
4
A
SER
70
-79.61
41.75
4
A
ILE
85
-154.92
-23.97
4
A
GLU
96
26.78
64.96
4
A
LYS
98
36.35
53.45
4
A
PRO
102
-50.73
-9.53
4
A
PRO
105
-54.36
170.98
5
A
PRO
26
-77.05
-142.97
5
A
PHE
30
-144.61
-2.18
5
A
GLN
32
-78.92
39.40
5
A
SER
70
-84.09
47.41
5
A
ILE
85
-157.92
-25.35
5
A
GLU
96
-154.64
-43.25
5
A
LYS
104
-132.94
-36.01
5
A
ARG
106
45.66
28.41
6
A
ARG
18
-128.76
-71.15
6
A
LYS
19
-150.34
-4.84
6
A
ILE
22
65.84
-45.35
6
A
TYR
27
71.80
177.91
6
A
LEU
28
-88.64
30.70
6
A
PHE
30
-146.23
-6.83
6
A
PRO
68
-58.69
-4.59
6
A
SER
72
-170.18
48.55
6
A
ALA
74
59.09
-62.72
6
A
ILE
85
-156.83
-33.88
6
A
GLU
96
-163.72
-31.65
7
A
PHE
30
-143.56
18.98
7
A
SER
72
-87.92
34.76
7
A
ALA
74
63.46
-54.95
7
A
ILE
85
-155.88
-27.64
7
A
GLU
95
-142.46
19.63
7
A
GLU
96
-143.56
-41.81
7
A
ASP
97
-98.73
44.78
7
A
LYS
98
-47.32
151.85
8
A
ARG
18
-127.88
-50.24
8
A
LYS
19
-137.69
-32.23
8
A
THR
20
-172.70
140.67
8
A
GLU
23
-52.42
-9.91
8
A
LEU
28
31.90
34.30
8
A
PHE
30
-148.06
-5.94
8
A
ARG
54
-137.21
-149.87
8
A
SER
70
-140.74
38.75
8
A
ALA
74
63.29
-35.93
8
A
ILE
85
-153.41
-31.30
8
A
GLU
96
-155.51
-40.48
8
A
PRO
102
-58.26
23.22
8
A
PRO
105
-61.89
30.52
8
A
ARG
106
50.53
-4.91
9
A
LYS
19
71.14
31.27
9
A
PRO
21
-76.81
26.73
9
A
ILE
22
53.66
-17.28
9
A
GLU
23
-56.97
-2.55
9
A
ARG
24
-69.70
44.50
9
A
ILE
25
-144.78
34.21
9
A
TYR
48
59.69
-47.27
9
A
ILE
85
-157.50
-26.99
9
A
LYS
93
-141.60
-23.11
9
A
GLU
95
-143.07
18.51
9
A
GLU
96
24.99
66.52
9
A
ARG
106
-148.03
-16.34
10
A
PRO
21
-48.49
152.18
10
A
GLU
23
-61.68
0.48
10
A
PHE
30
-150.32
8.67
10
A
GLN
32
-75.11
48.27
10
A
ILE
33
63.33
62.64
10
A
ASN
34
-63.92
62.60
10
A
ILE
85
-165.35
-31.93
10
A
GLU
96
28.65
51.95
10
A
PRO
102
-54.25
-5.56
11
A
PRO
26
-78.59
-158.06
11
A
LEU
28
-109.94
52.15
11
A
PRO
68
-51.65
-8.28
11
A
SER
70
-71.36
22.38
11
A
ILE
85
-161.63
-31.62
11
A
GLU
96
-151.71
-44.01
11
A
PRO
99
-79.72
34.22
HUMAN MRF-2 DOMAIN, NMR, 11 STRUCTURES
1
N
N
A
ARG
1
A
ARG
1
HELX_P
A
GLU
17
A
GLU
17
1
1
17
A
PRO
21
A
PRO
21
HELX_P
A
ILE
25
A
ILE
25
5
2
5
A
ASN
34
A
ASN
34
HELX_P
A
LEU
45
A
LEU
45
1
3
12
A
GLY
46
A
GLY
46
HELX_P
A
ARG
55
A
ARG
55
1
4
10
A
GLN
56
A
GLN
56
HELX_P
A
GLY
65
A
GLY
65
1
5
10
A
CYS
76
A
CYS
76
HELX_P
A
ILE
85
A
ILE
85
1
6
10
A
TYR
88
A
TYR
88
HELX_P
A
GLU
96
A
GLU
96
1
7
9
DNA BINDING PROTEIN
DNA BINDING PROTEIN, MRF-2, DNA-BINDING MOTIF, PROTEIN-DNA INTERACTION
ARI5B_HUMAN
UNP
1
17
Q14865
RADEQAFLVALYKYMKERKTPIERIPYLGFKQINLWTMFQAAQKLGGYETITARRQWKHIYDELGGNPGSTSAATCTRRH
YERLILPYERFIKGEEDKPLPPIKPRK
17
123
1IG6
1
107
Q14865
A
1
1
107
1
P 1